What’s Next For CAR T: The Potential of Engineering Immune Cells to Treat Cancer – R & D Magazine
R & D Magazine |
What's Next For CAR T: The Potential of Engineering Immune Cells to Treat Cancer
R & D Magazine CAR T-cell therapy is created by collecting a patient's T-cells, genetically modifying them to fight cancer, and then infusing them back into the patient. The first therapy in this class, tisagenlecleucel (Kymriah), was FDA approved in August 2017 in … Researchers Build a Cancer Immunotherapy Without Immune Cells |
